David Huen
Impact in
- Oncology top 2%
- Viral-associated cancers and disorders
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Epigenetics and DNA Methylation 5
- Insect Resistance and Genetics 4
- CRISPR and Genetic Engineering 4
- Oncology 10
- Viral-associated cancers and disorders 6
- Polyomavirus and related diseases 3
- Co-authors
- Martin Rowe (4 shared papers)Debbie Croom-Carter (2 shared papers)Alan B. Rickinson (4 shared papers)S. A. Henderson (2 shared papers)George S. Johnson (1 shared paper)Chris Dawson (1 shared paper)Steven Russell (6 shared papers)John Roote (2 shared papers)
- Journals
- Genetics (2 papers)PLoS ONE (2 papers)Genes & Development (2 papers)Journal of Medical Genetics (2 papers)Pharmaceutical Development and Technology (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
David Huen
29 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 102
- Oncology 846
- Pathology and Forensic Medicine 346
- Aging 37
- Immunology 339
- Molecular Biology 1.1k
Countries citing papers authored by David Huen
This map shows the geographic impact of David Huen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Huen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Huen more than expected).
Fields of papers citing papers by David Huen
This network shows the impact of papers produced by David Huen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Huen. The network helps show where David Huen may publish in the future.
Co-authors
The 25 scholars most cited alongside David Huen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 482 | |
| 2 | The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. | 1995 | 397 |
| 3 | 1999 | 223 | |
| 4 | 2008 | 195 | |
| 5 | 1994 | 166 | |
| 6 | 2001 | 136 | |
| 7 | 2005 | 70 | |
| 8 | 2008 | 68 | |
| 9 | 2011 | 51 | |
| 10 | 2014 | 51 | |
| 11 | 2013 | 42 | |
| 12 | 1994 | 38 | |
| 13 | 1996 | 35 | |
| 14 | 2013 | 31 | |
| 15 | 2018 | 30 | |
| 16 | 1995 | 20 | |
| 17 | 2019 | 18 | |
| 18 | The expression of the retinoblastoma gene product Rb1 in primary and adenovirus-transformed human cells. | 1989 | 16 |
| 19 | 1993 | 13 | |
| 20 | 2010 | 11 |
About David Huen
David Huen is a scholar working on Molecular Biology, Oncology, Rheumatology, Pathology and Forensic Medicine and Genetics, having authored 29 papers that have together received 2.1k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Epigenetics and DNA Methylation (5 papers), Insect Resistance and Genetics (4 papers), Eosinophilic Disorders and Syndromes (4 papers), CRISPR and Genetic Engineering (4 papers), Polyomavirus and related diseases (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (846 citations), Pathology and Forensic Medicine (346 citations), Aging (37 citations), Immunology (339 citations) and Molecular Biology (1.1k citations). David Huen has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Martin Rowe, Debbie Croom-Carter, Alan B. Rickinson, S. A. Henderson, George S. Johnson, Chris Dawson, Steven Russell, John Roote, David Gubb and Sarah A. Collier. Their work appears in journals such as Genetics, PLoS ONE, Genes & Development, Journal of Medical Genetics and Pharmaceutical Development and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.